Valneva SE (VALN) Cost of Revenue (2021 - 2026)

Valneva SE's (VALN) quarterly Cost of Revenue came in at $30.7 million in Q1 2026, up 26.45% year-on-year from $24.2 million in Q1 2025, and down 27.0% quarter-over-quarter from $42.0 million in Q4 2025.

Valneva SE (VALN) Cost of Revenue (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Cost of Revenue across 6 years of filings, most recently posting $30.7 million for Q1 2026.

  • Cost of Revenue for Q1 2026 came in at $30.7 million, up 26.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $127.9 million (up 19.73% YoY), and the FY2025 annual result was $124.7 million, up 18.44% from the prior year.
  • Cost of Revenue came in at $30.7 million for Q1 2026 at Valneva SE, down from $42.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $168.2 million in Q2 2022 to a low of $15.6 million in Q1 2022.
  • The 5-year median for Cost of Revenue is $28.0 million (2023), against an average of $41.6 million.
  • Peak annual rise in Cost of Revenue reached 593.86% in 2022, while the deepest fall reached 78.59% in 2022.
  • Valneva SE's Cost of Revenue stood at $124.2 million in 2022, then slumped by 77.42% to $28.0 million in 2023, then advanced by 3.76% to $29.1 million in 2024, then jumped by 44.29% to $42.0 million in 2025, then slipped by 27.0% to $30.7 million in 2026.
  • The last three Cost of Revenue figures came in at $30.7 million (Q1 2026), $42.0 million (Q4 2025), and $27.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 64.20 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 48,670.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 392.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - 2.05 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 30.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.65 Mn
Mar 31, 2026 30.65 Mn
Dec 31, 2025 41.99 Mn
Dec 31, 2025 41.99 Mn
Sep 30, 2025 27.95 Mn
Sep 30, 2025 27.95 Mn
Jun 30, 2025 27.30 Mn
Jun 30, 2025 27.30 Mn
Mar 31, 2025 24.24 Mn
Mar 31, 2025 24.24 Mn
Dec 31, 2024 29.10 Mn
Dec 31, 2024 29.10 Mn
Sep 30, 2024 28.20 Mn
Sep 30, 2024 28.20 Mn
Jun 30, 2024 25.27 Mn
Jun 30, 2024 25.27 Mn
Mar 31, 2024 24.07 Mn
Mar 31, 2024 24.07 Mn
Dec 31, 2023 28.04 Mn
Dec 31, 2023 28.04 Mn